Lumida
/AKTS
⌘K
AKTS

AKTS

AKTS
$23.30USD-2.67%-0.64 today

MARKET CAP

1.3B

P/E (TTM)

FWD P/E

DAY RANGE

$23 – $25

52W RANGE

$0
$34

AI Summary

Stalk
TrimMedium

AKTS is in a Stage 4 decline following a decisive support failure, reinforcing medium-term bearish bias while the long-term uptrend remains intact above the 200 DMA. Short-term conditions are oversold and no clear bounce is visible, suggesting timing favors waiting for a rally into the broken support-turned-resistance near the 9/20 EMAs and 50 SMA (~24.90–25.10) before trimming exposure.

  • Cash, cash equivalents, and marketable securities of $517.3M fund ops through 2029.
  • Q2 2026 revenue rose 113% YoY to $3.4M, reflecting pipeline traction.
  • Q2 net loss jumped to $24.1M from $18.1M year-ago, driven by R&D spend.
Full analysis →

Buying

6

institutions

Selling

4

institutions

New Positions

4

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY2.28 M73.43 M+166.23 K+94.3%0.00%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

SELL2.05 M66.12 M+-72.36 K+74.0%0.04%
JH

Janus Henderson Group Plc

Q1 2026

BUYNEW2.91 M52.04 M+2.91 M+0.0%0.01%
RC

Ra Capital Management, L.P.

Q2 2026

SELL1.31 M42.36 M+-188.68 K+57.5%0.37%
WP

Woodline Partners LP

Q2 2026

SELL100.00 K3.22 M+-100.00 K-9.9%0.01%
RT

Renaissance Technologies LLC

Q2 2026

BUYNEW95.40 K3.07 M+95.40 K+0.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUYNEW48.12 K1.55 M+48.12 K+0.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL25.54 K823.06 K+-49.46 K-38.7%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY8.84 K266.02 K+480.00+92.5%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUYNEW397.0012.79 K+397.00+0.0%0.00%